Application > Formulations Genexol®-PM is a type of drug-delivery formulation under the development of Samyang Co. (Korea). Genexol® enclosed by a polymer material (Genexol®-polymeric micelle), enhances the solubility of Genexol® and anticancer activity. OncoGel is a type of drug-delivery formulation under the development of MacroMed Inc. (USA). After injection into body as a liquid, OncoGel becomes a gel and active ingredient at body temperature. In this case Genexol®, is slowly released, which enables a constant drug release profile without an initial burst. ABI-007 is a type of drug-delivery formulation under the development of ABI(American Bioscience Inc.) Using albumin coating, which enhances the solubility of Genexol®, it has become an effective drug injection.